Syros Announces Closing of Concurrent Public Offerings Business Wire
Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today announced the closing of it.
Syros Announces Closing of Concurrent Public Offerings Business Wire
Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today announced the closing of it.